Good Faith Exam
for Semaglutide
$26.99 Per Exam
Nurse-Owned and Clinician-Led
Nationwide Coverage
Independent Medical Judgment
For Startups
For Established Practices
Semaglutide is one of the most prescribed weight loss medications in the country. It is also one of the most scrutinized. A good faith exam for semaglutide is the clinical evaluation that creates the documented patient-provider relationship required before a prescription is issued.
GoodFaithExams.com delivers that evaluation online so practices meet the standard without slowing down patient access.
What Is a Good Faith Exam for Semaglutide
Semaglutide is a GLP-1 receptor agonist. It is a prescription drug. That classification carries a clear legal requirement: a licensed provider must evaluate the patient and establish a valid patient-provider relationship before the medication is prescribed.
A good faith exam for semaglutide is that evaluation. A licensed physician reviews the patient’s health history, current medications, relevant metabolic and cardiovascular conditions, and contraindications specific to GLP-1 receptor agonists. They assess whether semaglutide is clinically appropriate for that specific patient.
Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, prior pancreatitis, and certain gastrointestinal conditions. Patients on insulin or other diabetes medications need a careful review of hypoglycemia risk. These are the clinical factors a proper evaluation identifies before a prescription is written.
Semaglutide good faith exam documentation creates the record showing a licensed provider reviewed this patient for this medication and made an independent clinical decision.
Why Semaglutide GFE Requirements Exist
Federal and state regulators have increased scrutiny of semaglutide prescribing, particularly in telehealth settings. Practices issuing GLP-1 prescriptions through automated intake without documented clinical evaluation have faced board complaints and federal enforcement actions.
Semaglutide GFE requirements exist because the medication’s popularity has outpaced compliance at many practices. A compliant good faith exam separates a defensible prescription from an exposed one.
Who Can Perform It
The provider must hold prescribing authority and be licensed within their scope. Qualified providers include physicians, nurse practitioners with prescribing authority and appropriate supervision agreements, and physician assistants with prescribing authority and appropriate supervision agreements.
GoodFaithExams.com connects patients with licensed physicians meeting state-specific prescribing and oversight requirements.
What to Expect
Patient Intake
Patients submit health history, current medications, metabolic and cardiovascular history, weight history, and the specific formulation being considered.
Provider Evaluation
A licensed physician reviews the case.
Clinical Decision
The provider approves, modifies, or declines based on independent judgment and contraindication review.
Documented Outcome
Each evaluation is recorded and delivered to the practice.
How GoodFaithExams.com Makes It Simple
An online GFE for semaglutide through GoodFaithExams.com is built for active GLP-1 prescribing volume.
Available Monday Through Sunday. No scheduling constraints.
Every exam is conducted by a licensed physician. No shortcuts. Every patient receives a real clinical evaluation, not a formality.
A good faith evaluation for semaglutide on GoodFaithExams.com reviews GLP-1-specific contraindications, thyroid history, pancreatic history, cardiovascular risk factors, and medication interaction profiles. Not a general clearance.
Pricing
$26.99 per exam.
No hidden fees. No monthly minimums. No contracts.
Who This Is and Is Not For
Good fit:
- Weight loss and GLP-1 prescribing practices, telehealth platforms prescribing semaglutide across multiple states, practices using compounded semaglutide formulations.
Not for:
- Clinics looking for shortcuts, businesses seeking legal advice, teams that do not want licensed provider involvement.
Ready to Get Started
Semaglutide prescribing requires a documented clinical evaluation from a licensed provider. A good faith exam for semaglutide through GoodFaithExams.com makes that evaluation fast, affordable, and defensible.
Start today at GoodFaithExams.com.
Frequently Asked Questions
What is a good faith exam for semaglutide?
A good faith exam for semaglutide is a required clinical evaluation conducted by a licensed physician before a semaglutide prescription is issued. It establishes the patient-provider relationship, reviews the patient’s health history and contraindications specific to GLP-1 receptor agonists, and creates the documented clinical basis for the prescription.
Why have regulators specifically targeted semaglutide prescribing practices?
Semaglutide’s rapid growth in telehealth weight loss programs led to widespread prescribing through automated intake systems without documented clinical evaluation. Federal agencies and state medical boards have both taken action against practices that issued GLP-1 prescriptions without a valid patient-provider relationship on file. The documented good faith exam is what separates a compliant prescription from a vulnerable one.
What contraindications does the semaglutide evaluation specifically look for?
The reviewing physician assesses personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, prior pancreatitis, significant gastrointestinal conditions, and concurrent use of insulin or other hypoglycemic medications. Each patient is reviewed individually before a prescribing decision is made.
Does the requirement apply to compounded semaglutide or only brand-name versions?
The evaluation requirement applies to semaglutide prescribing regardless of whether the formulation is Ozempic, Wegovy, or a compounded version. The requirement is tied to the medication class and the prescribing act, not the product source.
What are semaglutide GFE requirements and how do they vary by state?
Semaglutide GFE requirements specify that a licensed provider with prescribing authority must conduct a documented clinical evaluation before semaglutide is prescribed. The core standard is consistent across states. Specifics around supervision structures and provider types vary by jurisdiction.
What is a good faith evaluation for semaglutide and how is it different from intake?
A good faith evaluation for semaglutide requires a licensed physician to actively review the patient’s clinical profile, assess GLP-1-specific contraindications, and document an independent decision. Intake collects patient-reported information. An evaluation produces the clinical record that demonstrates provider judgment.
How does a telehealth good faith exam for semaglutide work?
The patient submits health history, current medications, and relevant metabolic information through the platform. A licensed physician reviews the case, assesses semaglutide suitability, and documents independent clinical findings. The practice receives the completed record. No coordination overhead required.
What is good faith exam telemedicine for semaglutide?
Good faith exam telemedicine for semaglutide is the completion of a required pre-prescribing clinical evaluation through a remote digital platform. GoodFaithExams.com provides this through licensed physicians who review every patient individually and document independent clinical decisions before semaglutide is prescribed.
Who qualifies as a semaglutide GFE provider?
A semaglutide GFE provider must be a licensed physician, nurse practitioner, or physician assistant with prescribing authority, operating within scope and meeting the state supervision and licensing requirements where the patient is located. GoodFaithExams.com uses only licensed physicians on the platform.
How does an online GFE for semaglutide protect my practice during a federal or state review?
It creates a documented record showing a licensed physician evaluated the patient, reviewed GLP-1-specific contraindications, and made an independent prescribing decision. That record is what medical boards and federal investigators ask for when reviewing semaglutide prescribing practices.
